Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The basophil-IL-4-mast cell axis is required for food allergy.

Kashiwakura JI, Ando T, Karasuyama H, Kubo M, Matsumoto K, Matsuda T, Kawakami T.

Allergy. 2019 Apr 21. doi: 10.1111/all.13834. [Epub ahead of print] No abstract available.

PMID:
31006132
2.

Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs.

Izaki S, Toyoshima S, Endo T, Kanegae K, Nunomura S, Kashiwakura JI, Sasaki-Sakamoto T, Nakamura R, Akiyama H, Ra C, Hayama K, Terui T, Okayama Y.

Allergol Int. 2019 Feb 22. pii: S1323-8930(19)30012-7. doi: 10.1016/j.alit.2019.01.003. [Epub ahead of print]

3.

STAP-2 positively regulates FcRI-mediated basophil activation and basophil-dependent allergic inflammatory reaction.

Kashiwakura JI, Yamashita S, Yoshihara M, Inui K, Saitoh K, Sekine Y, Muromoto R, Kitai Y, Oritani K, Matsuda T.

Int Immunol. 2019 Feb 6. doi: 10.1093/intimm/dxz013. [Epub ahead of print]

PMID:
30726917
4.

Characterization of human decidual mast cells and establishment of a culture system.

Matsuno T, Toyoshima S, Sakamoto-Sasaki T, Kashiwakura JI, Matsuda A, Watanabe Y, Azuma H, Kawana K, Yamamoto T, Okayama Y.

Allergol Int. 2018 Sep;67S:S18-S24. doi: 10.1016/j.alit.2018.05.001. Epub 2018 May 18.

5.

Crystal structures of murine and human Histamine-Releasing Factor (HRF/TCTP) and a model for HRF dimerisation in mast cell activation.

Doré KA, Kashiwakura JI, McDonnell JM, Gould HJ, Kawakami T, Sutton BJ, Davies AM.

Mol Immunol. 2018 Jan;93:216-222. doi: 10.1016/j.molimm.2017.11.022. Epub 2017 Dec 5.

6.

Histamine-releasing factor enhances food allergy.

Ando T, Kashiwakura JI, Itoh-Nagato N, Yamashita H, Baba M, Kawakami Y, Tsai SH, Inagaki N, Takeda K, Iwata T, Shimojo N, Fujisawa T, Nagao M, Matsumoto K, Kawakami Y, Kawakami T.

J Clin Invest. 2017 Dec 1;127(12):4541-4553. doi: 10.1172/JCI96525. Epub 2017 Nov 13.

7.

STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization.

Kitai Y, Iwakami M, Saitoh K, Togi S, Isayama S, Sekine Y, Muromoto R, Kashiwakura JI, Yoshimura A, Oritani K, Matsuda T.

J Biol Chem. 2017 Nov 24;292(47):19392-19399. doi: 10.1074/jbc.M117.802884. Epub 2017 Oct 6.

8.

Biochanin A enhances RORγ activity through STAT3-mediated recruitment of NCOA1.

Takahashi M, Muromoto R, Kojima H, Takeuchi S, Kitai Y, Kashiwakura JI, Matsuda T.

Biochem Biophys Res Commun. 2017 Aug 5;489(4):503-508. doi: 10.1016/j.bbrc.2017.05.181. Epub 2017 Jun 1.

9.

A Novel α9 Integrin Ligand, XCL1/Lymphotactin, Is Involved in the Development of Murine Models of Autoimmune Diseases.

Matsumoto N, Kon S, Nakatsuru T, Miyashita T, Inui K, Saitoh K, Kitai Y, Muromoto R, Kashiwakura JI, Uede T, Matsuda T.

J Immunol. 2017 Jul 1;199(1):82-90. doi: 10.4049/jimmunol.1601329. Epub 2017 May 26.

10.

STAP-2 interacts with Pyk2 and enhances Pyk2 activity in T-cells.

Saitoh K, Tsuchiya T, Kashiwakura JI, Muromoto R, Kitai Y, Sekine Y, Oritani K, Matsuda T.

Biochem Biophys Res Commun. 2017 Jun 17;488(1):81-87. doi: 10.1016/j.bbrc.2017.05.010. Epub 2017 May 3.

11.

Role of Histamine-releasing Factor in Allergic Inflammatory Reactions.

Kashiwakura JI, Ando T, Kawakami T.

Yakugaku Zasshi. 2017;137(5):517-521. doi: 10.1248/yakushi.16-00239-3. Review. Japanese.

12.

Frontiers in Researches of Allergy.

Nishida K, Kashiwakura JI.

Yakugaku Zasshi. 2017;137(5):493-494. doi: 10.1248/yakushi.16-00239-F. Japanese. No abstract available.

13.

The dual regulation of substance P-mediated inflammation via human synovial mast cells in rheumatoid arthritis.

Okamura Y, Mishima S, Kashiwakura JI, Sasaki-Sakamoto T, Toyoshima S, Kuroda K, Saito S, Tokuhashi Y, Okayama Y.

Allergol Int. 2017 Sep;66S:S9-S20. doi: 10.1016/j.alit.2017.03.002. Epub 2017 Mar 31.

14.

Interleukin-17A expression in human synovial mast cells in rheumatoid arthritis and osteoarthritis.

Kan J, Mishima S, Kashiwakura J, Sasaki-Sakamoto T, Seki M, Saito S, Ra C, Tokuhashi Y, Okayama Y.

Allergol Int. 2016 Sep;65 Suppl:S11-6. doi: 10.1016/j.alit.2016.04.007. Epub 2016 May 18.

15.

[The role of histamine-releasing factor in allergic inflammation].

Kashiwakura J.

Seikagaku. 2015 Dec;87(6):766-9. Review. Japanese. No abstract available.

PMID:
26863759
16.

MIP-1α level in nasopharyngeal aspirates at the first wheezing episode predicts recurrent wheezing.

Sugai K, Kimura H, Miyaji Y, Tsukagoshi H, Yoshizumi M, Sasaki-Sakamoto T, Matsunaga S, Yamada Y, Kashiwakura J, Noda M, Ikeda M, Kozawa K, Ryo A, Yoshihara S, Ogata H, Okayama Y.

J Allergy Clin Immunol. 2016 Mar;137(3):774-81. doi: 10.1016/j.jaci.2015.08.032. Epub 2015 Oct 19.

PMID:
26494023
17.

Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria.

Fujisawa D, Kashiwakura J, Kita H, Kikukawa Y, Fujitani Y, Sasaki-Sakamoto T, Kuroda K, Nunomura S, Hayama K, Terui T, Ra C, Okayama Y.

J Allergy Clin Immunol. 2014 Sep;134(3):622-633.e9. doi: 10.1016/j.jaci.2014.05.004. Epub 2014 Jun 19.

PMID:
24954276
18.

Signal-transducing adaptor protein-2 controls the IgE-mediated, mast cell-mediated anaphylactic responses.

Sekine Y, Nishida K, Yamasaki S, Muromoto R, Kon S, Kashiwakura J, Saitoh K, Togi S, Yoshimura A, Oritani K, Matsuda T.

J Immunol. 2014 Apr 15;192(8):3488-95. doi: 10.4049/jimmunol.1300886. Epub 2014 Mar 10.

19.

Critical role for mast cell Stat5 activity in skin inflammation.

Ando T, Xiao W, Gao P, Namiranian S, Matsumoto K, Tomimori Y, Hong H, Yamashita H, Kimura M, Kashiwakura J, Hata TR, Izuhara K, Gurish MF, Roers A, Rafaels NM, Barnes KC, Jamora C, Kawakami Y, Kawakami T.

Cell Rep. 2014 Jan 30;6(2):366-76. doi: 10.1016/j.celrep.2013.12.029. Epub 2014 Jan 9.

20.

Histamine-releasing factor and immunoglobulins in asthma and allergy.

Kawakami T, Kashiwakura J, Kawakami Y.

Allergy Asthma Immunol Res. 2014 Jan;6(1):6-12. doi: 10.4168/aair.2014.6.1.6. Epub 2013 Jul 2. Review.

21.

Highly expressed cytoplasmic FcεRIβ in human mast cells functions as a negative regulator of the FcRγ-mediated cell activation signal.

Okayama Y, Matsuda A, Kashiwakura JI, Sasaki-Sakamoto T, Nunomura S, Shimokawa T, Yamaguchi K, Takahashi S, Ra C.

Clin Exp Allergy. 2014 Feb;44(2):238-49. doi: 10.1111/cea.12210.

PMID:
24118172
22.

Significantly high levels of anti-dsDNA immunoglobulin E in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients.

Hatada Y, Kashiwakura J, Hayama K, Fujisawa D, Sasaki-Sakamoto T, Terui T, Ra C, Okayama Y.

Int Arch Allergy Immunol. 2013;161 Suppl 2:154-8. doi: 10.1159/000350388. Epub 2013 May 29.

PMID:
23711867
23.

Interleukin-33 synergistically enhances immune complex-induced tumor necrosis factor alpha and interleukin-8 production in cultured human synovium-derived mast cells.

Kashiwakura J, Yanagisawa M, Lee H, Okamura Y, Sasaki-Sakamoto T, Saito S, Tokuhashi Y, Ra C, Okayama Y.

Int Arch Allergy Immunol. 2013;161 Suppl 2:32-6. doi: 10.1159/000350424. Epub 2013 May 29.

PMID:
23711851
24.

Interaction between conjunctival epithelial cells and mast cells induces CCL2 expression and piecemeal degranulation in mast cells.

Iwamoto S, Asada Y, Ebihara N, Hori K, Okayama Y, Kashiwakura J, Watanabe Y, Kawasaki S, Yokoi N, Inatomi T, Shinomiya K, Murakami A, Matsuda A.

Invest Ophthalmol Vis Sci. 2013 Apr 3;54(4):2465-73. doi: 10.1167/iovs.12-10664.

PMID:
23482464
25.

Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition.

Takahashi M, Izawa K, Kashiwakura J, Yamanishi Y, Enomoto Y, Kaitani A, Maehara A, Isobe M, Ito S, Matsukawa T, Nakahara F, Oki T, Kajikawa M, Ra C, Okayama Y, Kitamura T, Kitaura J.

J Biol Chem. 2013 Mar 15;288(11):7662-75. doi: 10.1074/jbc.M112.434746. Epub 2013 Jan 31.

26.

Most Highly Cytokinergic IgEs Have Polyreactivity to Autoantigens.

Kashiwakura J, Okayama Y, Furue M, Kabashima K, Shimada S, Ra C, Siraganian RP, Kawakami Y, Kawakami T.

Allergy Asthma Immunol Res. 2012 Nov;4(6):332-40. doi: 10.4168/aair.2012.4.6.332. Epub 2012 Jun 25.

27.

Activation of human synovial mast cells from rheumatoid arthritis or osteoarthritis patients in response to aggregated IgG through Fcγ receptor I and Fcγ receptor II.

Lee H, Kashiwakura J, Matsuda A, Watanabe Y, Sakamoto-Sasaki T, Matsumoto K, Hashimoto N, Saito S, Ohmori K, Nagaoka M, Tokuhashi Y, Ra C, Okayama Y.

Arthritis Rheum. 2013 Jan;65(1):109-19. doi: 10.1002/art.37741.

28.

[Heterogeneity of human mast cells].

Okayama Y, Kashiwakura J, Ra C.

Arerugi. 2012 Jun;61(6):792-7. Review. Japanese. No abstract available.

PMID:
22868518
29.

The interaction between Lyn and FcεRIβ is indispensable for FcεRI-mediated human mast cell activation.

Okayama Y, Kashiwakura JI, Matsuda A, Sasaki-Sakamoto T, Nunomura S, Yokoi N, Ebihara N, Kuroda K, Ohmori K, Saito H, Ra C.

Allergy. 2012 Oct;67(10):1241-9. doi: 10.1111/j.1398-9995.2012.02879.x.. Epub 2012 Jul 30.

PMID:
22845063
30.

Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.

Okayama Y, Kashiwakura J, Sasaki-Sakamoto T, Matsumoto K, Hashimoto N, Ohmori K, Kawakami T, Saito H, Ra C.

Ann Allergy Asthma Immunol. 2012 Mar;108(3):188-94. doi: 10.1016/j.anai.2012.01.009.

PMID:
22374203
31.

Histamine-releasing factor has a proinflammatory role in mouse models of asthma and allergy.

Kashiwakura JC, Ando T, Matsumoto K, Kimura M, Kitaura J, Matho MH, Zajonc DM, Ozeki T, Ra C, MacDonald SM, Siraganian RP, Broide DH, Kawakami Y, Kawakami T.

J Clin Invest. 2012 Jan;122(1):218-28. doi: 10.1172/JCI59072. Epub 2011 Dec 1.

32.

Monomeric IgE and mast cell development, survival and function.

Kashiwakura J, Otani IM, Kawakami T.

Adv Exp Med Biol. 2011;716:29-46. doi: 10.1007/978-1-4419-9533-9_3. Review.

PMID:
21713650
33.

Phospholipase C-β3 regulates FcɛRI-mediated mast cell activation by recruiting the protein phosphatase SHP-1.

Xiao W, Kashiwakura J, Hong H, Yasudo H, Ando T, Maeda-Yamamoto M, Wu D, Kawakami Y, Kawakami T.

Immunity. 2011 Jun 24;34(6):893-904. doi: 10.1016/j.immuni.2011.04.010. Epub 2011 Jun 16.

34.

JNK1 controls mast cell degranulation and IL-1{beta} production in inflammatory arthritis.

Guma M, Kashiwakura J, Crain B, Kawakami Y, Beutler B, Firestein GS, Kawakami T, Karin M, Corr M.

Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22122-7. doi: 10.1073/pnas.1016401107. Epub 2010 Dec 6.

35.

FcepsilonRI beta-chain ITAM amplifies PI3K-signaling to ensure synergistic degranulation response via FcepsilonRI and adenosine receptors.

Nunomura S, Gon Y, Yoshimaru T, Kashiwakura J, Kawakami T, Ra C.

Eur J Immunol. 2010 Apr;40(4):1205-17. doi: 10.1002/eji.200939651.

36.

Polyclonal IgE induces mast cell survival and cytokine production.

Kashiwakura J, Kawakami Y, Yuki K, Zajonc DM, Hasegawa S, Tomimori Y, Caplan B, Saito H, Furue M, Oettgen HC, Okayama Y, Kawakami T.

Allergol Int. 2009 Sep;58(3):411-9. doi: 10.2332/allergolint.08-OA-0080. Epub 2009 Jun 25.

37.

Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype.

Kashiwakura J, Xiao W, Kitaura J, Kawakami Y, Maeda-Yamamoto M, Pfeiffer JR, Wilson BS, Blank U, Kawakami T.

J Leukoc Biol. 2008 Aug;84(2):357-67. doi: 10.1189/jlb.1207841. Epub 2008 May 13.

38.

Gene expression profiling of human mast cell subtypes: an in silico study.

Saito H, Matsumoto K, Okumura S, Kashiwakura J, Oboki K, Yokoi H, Kambe N, Ohta K, Okayama Y.

Allergol Int. 2006 Jun;55(2):173-9.

40.
41.

Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease.

Takeno M, Shimoyama Y, Kashiwakura J, Nagafuchi H, Sakane T, Suzuki N.

Rheumatol Int. 2004 Jul;24(4):212-6. Epub 2003 Jul 15.

PMID:
12879269
42.

Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI.

Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H, Okayama Y.

Blood. 2003 Oct 1;102(7):2547-54. Epub 2003 Jul 10.

43.
44.

Evidence of autophosphorylation in Txk: Y91 is an autophosphorylation site.

Kashiwakura J, Suzuki N, Takeno M, Itoh S, Oku T, Sakane T, Nakajin S, Toyoshima S.

Biol Pharm Bull. 2002 Jun;25(6):718-21.

45.
46.

Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon gamma production in human T lymphocytes.

Kashiwakura J, Suzuki N, Nagafuchi H, Takeno M, Takeba Y, Shimoyama Y, Sakane T.

J Exp Med. 1999 Oct 18;190(8):1147-54.

47.

The female X-inactivation mosaic in SLE.

Takeno M, Kashiwakura J, Sakane T.

Immunol Today. 1999 Mar;20(3):152-3. No abstract available.

PMID:
10203707

Supplemental Content

Loading ...
Support Center